Publications by authors named "Mario Furlanut"

Claim this Profile
E
Educational and organizational interventions to improve the usefulness of clinical pharmacological advice for personalized drug dosing based on therapeutic drug monitoring.
Federico Pea, Lucia Dose, Piergiorgio Cojutti, Massimo Baraldo, Fabrizio Fontana, Mario Furlanut

Basic Clin Pharmacol Toxicol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.
Federico Pea, Pierluigi Viale, Piergiorgio Cojutti, Mario Furlanut

Antimicrob Agents Chemother· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.
Federico Pea, Pierluigi Viale, Piergiorgio Cojutti, Barbara Del Pin, Eleonora Zamparini, Mario Furlanut

J Antimicrob Chemother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy.
Federico Pea, Piergiorgio Cojutti, Alberto Pagotto, Francesco Cristini, Mario Furlanut

Antimicrob Agents Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Federico Pea, Piergiorgio Cojutti, Nicola Petrosillo, Mario Furlanut, J M Entenza

Antimicrob Agents Chemother· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient.
Federico Pea, Piergiorgio Cojutti, Rodolfo Sbrojavacca, Barbara Cadeo, Francesco Cristini, Mario Furlanut

Ann Pharmacother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.
Federico Pea, Mario Furlanut, Piergiorgio Cojutti, Francesco Cristini, Eleonora Zamparini

Antimicrob Agents Chemother· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-α.
Mario Furlanut, Giorgio Soardo, Debora Donnini, Leonardo Sechi, Loretta Franceschi

Clin Pharmacokinet· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function?
Federico Pea, Mario Furlanut, Pierluigi Viale

J Trauma· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?
Federico Pea, Mario Furlanut, Pierluigi Viale

Antimicrob Agents Chemother· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
Federico Pea, Mario Furlanut, Camilla Negri, Federica Pavan, Massimo Crapis

Antimicrob Agents Chemother· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
Pierluigi Viale, Mario Furlanut, Luigia Scudeller, Federica Pavan, Camilla Negri

Int J Antimicrob Agents· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies.
Loretta Franceschi, Anna Faggiani, Mario Furlanut

J Pharm Biomed Anal· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients.
Federico Pea, Pierluigi Viale, Manuela Lugano, Umberto Baccarani, Federica Pavan, Mario Furlanut

J Antimicrob Chemother· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.
Federico Pea, Federica Pavan, Mario Furlanut

Clin Pharmacokinet· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
Federico Pea, Umberto Baccarani, Marcello Tavio, Piergiorgio Cojutti, Gian Luigi Adani, Mario Furlanut

Ann Pharmacother· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
Federico Pea, Marcello Tavio, Federica Pavan, Angela Londero, Vittorio Bresadola, Mario Furlanut

Antivir Ther· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
Federico Pea, Pierluigi Viale, Federica Pavan, Mario Furlanut

Clin Pharmacokinet· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen and its main metabolites serum and tissue concentrations in breast cancer women.
Mario Furlanut, Loretta Franceschi, Enrico Pasqual, Stefano Bacchetti, Donatella Poz

Ther Drug Monit· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis.
Pierluigi Viale, Mario Furlanut, Francesco Cristini, Barbara Cadeo, Federica Pavan

Diagn Microbiol Infect Dis· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose.
Federico Pea, Gino Marioni, Federica Pavan, Claudia Staffieri, Raffaele Bottin, Mario Furlanut

Pharmacol Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronopharmacokinetics of ciclosporin and tacrolimus.
Massimo Baraldo, Mario Furlanut

Clin Pharmacokinet· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.
Federico Pea, Donatella Poz, Pierluigi Viale, Federica Pavan, Mario Furlanut

J Antimicrob Chemother· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin.
Federico Pea, Pierluigi Viale, Federica Pavan, Marcello Tavio, Donatella Poz, Mario Furlanut

Int J Antimicrob Agents· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute oxcarbazepine, benazepril, and hydrochlorothiazide overdose with alcohol.
Mario Furlanut, Loretta Franceschi, Donatella Poz, Luciano Silvestri, Maurizio Pecorari

Ther Drug Monit· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis